PATENT CLAIM ANALYSIS

Application Number: 16080833
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "459000"]

Abstract:
Therapy for influenza using a combination of a neuraminidase inhibitor, a macrolide antibiotic, and a non-steroidal anti-inflammatory drug has been found to provide improved clinical outcomes and reduced incidence of viral quasispecies compared to conventional treatment with neuraminidase inhibitors alone. Effective treatment schedules are also provided. The drug combination can be used in concert with a proton-pump inhibitor and/or an additional antibacterial antibiotic.

Claim (Index 41):
A composition for treating infection with an influenza virus, comprising:\n a neuraminidase inhibitor; a macrolide antibiotic; and a non-steroidal anti-inflammatory drug.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 96.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15310836', '11057671', '12705219', '11112138', '15348253']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7501382702857751
- 35 USC 102 Novelty (BERT): 0.4744644270495778
- Combined Prediction Score: 0.7225708859621554
- Mean Citation Score: 175.717926
- Max Citation Score: 182.48404
- Similarity Product: 137.6985931800175

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test